CATABASIS PHARMACEUTICALS IN's ticker is and the CUSIP is 14875P206. A total of 26 filers reported holding CATABASIS PHARMACEUTICALS IN in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $46,000 | +100.0% | 21,811 | +168.4% | 0.00% | – |
| Q1 2021 | $23,000 | +21.1% | 8,126 | -9.3% | 0.00% | – |
| Q4 2020 | $19,000 | -77.1% | 8,959 | -33.8% | 0.00% | – |
| Q3 2020 | $83,000 | +112.8% | 13,539 | +123.1% | 0.00% | – |
| Q2 2020 | $39,000 | -25.0% | 6,068 | -51.3% | 0.00% | – |
| Q1 2020 | $52,000 | -83.2% | 12,463 | -76.3% | 0.00% | – |
| Q4 2019 | $310,000 | +79.2% | 52,490 | +63.5% | 0.00% | – |
| Q3 2019 | $173,000 | -49.0% | 32,111 | -26.0% | 0.00% | – |
| Q2 2019 | $339,000 | +313.4% | 43,406 | +321.4% | 0.00% | – |
| Q1 2019 | $82,000 | – | 10,300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samsara BioCapital, LLC | 300,000 | $2,421,000 | 1.60% |
| SV Health Investors, LLC | 285,765 | $2,306,000 | 1.55% |
| Alyeska Investment Group, L.P. | 1,125,000 | $9,079,000 | 0.12% |
| FEDERATED HERMES, INC. | 2,189,400 | $17,668,000 | 0.04% |
| OXFORD ASSET MANAGEMENT LLP | 139,451 | $1,125,000 | 0.02% |
| OPPENHEIMER & CO INC | 68,706 | $554,000 | 0.02% |
| RMB Capital Management, LLC | 60,618 | $489,000 | 0.01% |
| Blackstone Inc. | 200,819 | $1,621,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 20,900 | $169,000 | 0.00% |
| DIMENSIONAL FUND ADVISORS LP | 218,651 | $1,765,000 | 0.00% |